How is the Antibody Contract Manufacturing Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the antibody contract manufacturing market grown over the years?
In the past years, the market size of antibody contract manufacturing has seen significant expansion. The increase will take the market from $14.8 billion in 2024 to reach a peak of $16.84 billion in 2025, achieving a compound annual growth rate (CAGR) of 13.8%. Factors such as a heightened need for monoclonal antibodies, a shift in favor of personalized medicine, cost-effectiveness, strict regulatory standards, and globalized biologics have contributed to the growth observed in the historical period.
What Is the forecasted market size and growth rate for the antibody contract manufacturing market?
The market size for antibody contract manufacturing is poised for significant expansion in the coming years, predicted to reach $29.86 billion by 2029, with a compound annual growth rate (CAGR) of 15.4%. The upsurge during the projection period can be credited to factors like increased research and development expenditure, the proliferation of bispecific and multispecific antibodies, the emergence of antibody-drug conjugates (ADCs), advancements in healthcare infrastructure and growing government actions. Key trends expected within the forecast period encompass digitalization and data analytics, evolved upstream technologies, innovative downstream processing methods, sustainability efforts, and integration of contract development and manufacturing (CDMO).
Get your antibody contract manufacturing market report here!
What are the major factors driving growth in the antibody contract manufacturing market?
The antibody contract manufacturing market anticipates growth due to an increase in clinical trials. Clinical trials, which are research studies assessing the safety and efficiency of new medical treatments, interventions or diagnostic procedures with human participants are growing involving antibody-based therapies or diagnostics. This is to attain high-quality antibodies and assure a prompt, regulation compliant supply for clinical trials. For example, ClinicalTrials.gov, associated with the National Institutes of Health (NIH), a US government agency that leads and assists medical research in all 50 US states and 221 other countries, reported that registered clinical trials escalated from 399,499 in 2022 to 437,533 in 2023 in May itself. Moreover, approximately 241,498 studies, constituting 53% of the total, were registered outside the US, compared to 140,492 studies, representing 31%, which were registered in the US only. Consequently, the escalating number of clinical trials is fuelling the antibody contract manufacturing market’s expansion.
What key areas define the segmentation of the global antibody contract manufacturing Market?
The antibody contract manufacturing market covered in this report is segmented –
1) By Product: Monoclonal Antibodies, Polyclonal Antibodies, Other Products
2) By Source: Mammalian, Microbial
3) Scale Of Operation: Preclinical, Clinical, Commercial
4) By End-User: Biopharmaceutical Companies, Research Laboratories, Other End Users
Subsegments:
1) By Monoclonal Antibodies: Therapeutic Monoclonal Antibodies, Diagnostic Monoclonal Antibodies
2) By Polyclonal Antibodies: Research Polyclonal Antibodies, Therapeutic Polyclonal Antibodies
3) By Other Products: Bispecific Antibodies, Antibody-Drug Conjugates (ADCs), Fusion Proteins
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12665&type=smp
What are the top market players propelling the growth of the antibody contract manufacturing industry?
Major companies operating in the antibody contract manufacturing market include AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim Biopharmaceuticals GmbH, Fujifilm Holdings Corporation, Eurofins Scientific SE, Lonza Group AG, Labcorp Drug Development, Catalent Inc., Charles River Laboratories International Inc., Merck KGaA, Samsung Biologics Co. Ltd., Wuxi Biologics Cayman Inc, Siegfried Holding AG, Recipharm AB, Emergent BioSolutions Inc., Aenova Group, Cambrex Corporation, Aldevron LLC, Novasep Holding SAS, Synthon, KBI Biopharma Inc., Nitto Avecia Pharma Services Inc., Cytovance Biologics Inc., AGC Biologics S.p.A.
What are the key trends shaping the future of the antibody contract manufacturing market?
One trend observed in the antibody contract manufacturing industry is that top corporations are emphasizing on innovations such as single-use technology to decrease the risk of cross-contamination and cut operational expenses. Single-use technology (SUT) involves the utilization of single-use systems and components in the manufacturing protocols of biopharmaceuticals. For example, Merck & Co., a pharmaceutical firm based in the United States, introduced the Mobius ADC Reactor in September 2024. This reactor was developed specifically for the production of antibody-drug conjugates and offers an impressive efficiency increase of 70% over traditional stainless steel or glass methods. The single-use approach helps in reducing cross-contamination threats and managing operational costs, resulting in speedier turnaround times. Moreover, the enhanced film technology contributes to a more robust bag and greater leak prevention, maintaining the high integrity of highly potent active pharmaceutical components. This novel innovation assists biopharmaceutical corporations in the safer and more effective generation of crucial therapies.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12665
What regions are dominating the antibody contract manufacturing market growth?
North America was the largest region in the antibody contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Pharmaceutical API Manufacturing Global Market Report 2024
Manufacturing Execution System Global Market Report 2024
Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
